Dexcom (DXCM) Net Cash Flow Growth (5y) (2015 - 2026)
Dexcom (DXCM) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.34 Bn | 18.93 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.09% |
| Mar 31, 2026 | 34.60% |
| Dec 31, 2025 | -53.20% |
| Sep 30, 2025 | 36.54% |
| Jun 30, 2025 | 44.53% |
| Mar 31, 2025 | 16.36% |
| Dec 31, 2024 | -15.76% |
| Sep 30, 2024 | -0.91% |
| Jun 30, 2024 | 16.60% |
| Mar 31, 2024 | 14.30% |
| Dec 31, 2023 | -16.09% |
| Sep 30, 2023 | -59.12% |
| Jun 30, 2023 | 46.77% |
| Mar 31, 2023 | -0.20% |
| Dec 31, 2022 | -28.89% |
| Sep 30, 2022 | -57.50% |
| Jun 30, 2022 | -37.29% |
| Mar 31, 2022 | -50.29% |
| Dec 31, 2021 | -156.83% |
| Sep 30, 2021 | 94.55% |